IPMN Clinical Trial
Official title:
Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012
Purpose:
To investigate diagnostic performance of CT and MR in intraductal papillary mucinous
neoplasm with malignant change according to international consensus guidelines 2012.
Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main
pancreatic duct size of larger than 10 mm will be significant.
1. Purpose
- To investigate diagnostic performance of CT and MR in intraductal papillary
mucinous neoplasm with malignant change according to international consensus
guidelines 2012
2. Enroll criteria
- Patient who is suspected to have pancreas IPMN on imaging
- Interval between imaging study and surgery is less than 2 months
- Who is scheduled for surgery due to IPMN
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT04306939 -
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
|
||
| Not yet recruiting |
NCT03131076 -
Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN
|
N/A | |
| Recruiting |
NCT04993846 -
Pancreatic Cancer and Oral Microbiome
|
||
| Active, not recruiting |
NCT04207944 -
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
|
Phase 2 | |
| Active, not recruiting |
NCT03305146 -
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
|
N/A | |
| Completed |
NCT03914950 -
TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer
|
N/A | |
| Completed |
NCT03578445 -
Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions
|
N/A | |
| Recruiting |
NCT05117723 -
Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
|